| 单词 | Diovan |
| 例句 | Recent examples include cholesterol fighter Lipitor, blood thinner Plavix and blood pressure drug Diovan. AARP survey: Many generic medicine prices have risen sharply 2015-05-28T04:00:00Z Mylan earlier this week announced the U.S. launch of Valsartan tablets, a generic version of its Diovan hypertension drug. Teva Pharmaceuticals Hopes $40 Billion Mylan Deal Will Fuel Stock Rebound 2015-04-21T04:00:00Z The biggest selling drug of all time, Lipitor, is part of the Class of ’96, as are other cardiovascular drugs including Diovan. FDA Approvals 1996 vs. 2014: The Two Most Prolific Years, But Stark Differences 2015-01-07T05:00:00Z Novartis managers went through this type of exercise when the popular drug Diovan, which treats high blood pressure and heart failure, was about to lose its patent protection. Go Forth, Strategize: How Apple, Google, Novartis, Accel Partners Leverage Strategic Offsites 2014-10-08T04:00:00Z LCZ696 combines valsartan, the active ingredient in Diovan, with a new chemical to block neprilysin, which degrades chemicals that are involved in causing blood vessels to constrict. Novartis' Game Changer: When Failure Turns To Success 2014-09-02T04:00:00Z Epstein said the profitability of the new drug would be higher than with Diovan, since the cost of marketing LCZ696 will be lower. 'Most exciting ever' Novartis drug points to huge sales 2014-09-01T04:00:00Z One is valsartan, the blockbuster heart drug that Novartis sells as Diovan. New Novartis Drug Shows Striking Efficacy in Treating Heart Failure 2014-08-30T04:00:00Z Reinhardt said Novartis' profitability was only temporarily under pressure due to quality issues in the U.S. and Canada, the fact that the vaccines division was not profitable and falling sales of its former blockbuster Diovan. Novartis chairman rules out merger with Roche: paper 2014-03-02T11:10:48Z The Basel-based firm attributed the closure to declining sales of Diovan, a best-selling drug that lost its patent rights in the United States in 2012, making it vulnerable to competition from cheaper, copycat drugs. Novartis to cut 500 jobs in shutting U.S. Diovan plant 2014-01-22T17:19:04Z Novartis lost its patent rights on Diovan in the United States last year and already faces some generic competition. Novartis lifts profit forecast for second quarter in a row 2013-10-22T09:37:06Z The other three universities that published research on Diovan are still investigating the matter. Novartis says "deep regret" over Japan drug trials scandal 2013-09-26T13:13:16Z These include its version of Diovan, a successful treatment for high blood pressure whose patent, owned by Novartis of Switzerland, expired last year. Pharmaceuticals: Ranbaxy’s chronic maladies 2013-09-19T14:59:24Z Food and Drug Administration announced an import alert against one of Ranbaxy’s Indian manufacturing facilities that was going to produce a generic version of Diovan, a blood-pressure medication made by Novartis. India's Drugmaking Ambitions Suffer a Big Setback 2013-09-16T15:32:17Z The maker of blockbuster blood pressure drug Diovan said it would use a stem-cell based platform developed by U.S.-based biopharmaceutical company Regenerex to help broaden its cell therapy portfolio. Novartis signs deal to boost cell therapy portfolio 2013-09-06T05:53:34Z However, the company cautioned the delay in a generic competitor to Diovan would push the hit from that into 2014. Novartis lifts profit forecast for second quarter in a row 2013-10-22T09:37:06Z Effectively when you swallow one of our digital drugs it will say, Hello I'm here, I'm Novartis, I'm Diovan, 1.2mg, The pill that texts you - from inside 2013-08-08T23:16:55Z Diovan, which is generically known as Valsartan, is a treatment for high blood pressure which lost U.S. patent protection last year. Novartis Lifts Sales Outlook Despite Profit Dip 2013-07-17T07:16:27Z Closely monitor blood pressure, renal function and electrolytes in patients on Diovan and other agents that affect the RAS. European Medicines Agency Starts Review of Combined Use Of Drugs That Block The Renin-Angiotensin System 2013-05-20T21:31:37Z Mylan is exclusively selling a related drug, a combination of Diovan and a diuretic, whose patent protection also expired in September. Mylan Sues F.D.A. Over Ranbaxy’s Rights to Diovan 2012-12-07T02:52:37Z Like many of its rivals, Novartis is facing headwinds as some of its top earners lose patent protection, particularly blood pressure drug Diovan. Novartis says may have 14 new blockbuster drugs by 2017 2012-11-08T13:31:20Z Novartis saw annual revenues of $5.6 billion from Diovan, Jimenez said, and the drug's loss of exclusivity in Europe and the United states meant the firm would face three "very challenging quarters". Novartis CEO keen to keep dividend, big M&A not likely 2012-10-08T11:52:57Z Like many of its rivals, Novartis is struggling to grow in the face of patent expiries on key drugs, particularly Diovan for high blood pressure. Novartis CEO keen to keep dividend, big M&A not likely-paper 2012-10-07T10:56:41Z The medicines include staples in the American medicine cabinet - cholesterol fighter Lipitor, blood thinner Plavix and blood pressure drug Diovan - along with drugs for depression and breast cancer. New coupons aim to keep people off generic drugs 2012-08-20T20:46:05Z “This is right in the thick of the Diovan patent expiration,” says chief executive Joseph Jimenez. Novartis Pushes Through Patent Storm By Launching New Drugs In China, Europe 2012-07-19T17:14:02Z The loss of Diovan exclusivity hit sales in Europe, compounding a difficult period for Novartis in the region still gripped by economic crisis. New drugs shore up Novartis in Q2 2012-07-19T10:43:08Z The combination of the job cuts and strategic shift “should increase confidence that margins in pharmaceuticals are sustainable even as Novartis goes through the Diovan patent expiry,” Koch wrote. Novartis to Cut U.S. 1,960 Jobs, Take Charge 2012-01-14T11:06:40Z Novartis sees annual revenues of $5.6 billion from Diovan, Jimenez said, and the drug's loss of exclusivity in Europe and the United states meant the firm would face three "very challenging quarters". Novartis CEO keen to keep dividend, big M&A not likely-paper 2012-10-07T10:56:41Z The company said today it will take $1.22 billion of charges to prepare for generic competition to Diovan and reflect lower sales potential for its Tekturna medicine. Europe Drugmakers May Boost Acquisitions After Buyback Focus 2012-01-13T09:34:26Z Manufacturing woes: In addition to the Diovan patent expiration, Jimenez is facing two sets of manufacturing problems that are dragging on both sales and earnings. Novartis Pushes Through Patent Storm By Launching New Drugs In China, Europe 2012-07-19T17:14:02Z Between now and the loss of Diovan and Gleevec, only respiratory is big enough in our view to support that statement.” Novartis to Cut 2,000 Swiss, U.S. Jobs, Add Positions in China 2011-10-25T11:24:01Z Like many pharmaceutical companies, Novartis is starting to face generic competition, with its breast cancer drug Femara and its blood pressure medicine Diovan losing patent protection. Novartis cut 2,500 jobs globally: report 2011-09-25T15:51:57Z Diovan sales continue to rise in those fast-growing parts of the world even though the drug costs more than generic versions. How Novartis Plans to Avoid the 'Patent Cliff' 2011-08-04T20:45:19Z The loss of Diovan sales to generics was not as severe as expected, Chief Executive Officer Joe Jimenez said on a conference call. Novartis Gains as First-Quarter Profit, Sales Beat Estimates 2011-04-19T08:33:31Z Novartis’s best-selling drug, the hypertension treatment Diovan, began to lose patent protection in Europe in February. Novartis Aims to Resurrect ‘Zombie’ Drug in EU After Four Years 2011-04-06T05:45:44Z The buyout should also help the Swiss company mitigate a steep sales drop from lost patent protection for its two biggest medicines, heart drug Diovan and cancer drug Glivec. Novartis Buys Rest of Alcon 2010-12-15T19:14:32Z The Swiss drugmaker is hoping the Alcon deal, worth some $52 billion in total, will help it diversify and protect it against patent loss on big selling medicines such as blood pressure drug Diovan. Novartis wins Alcon with cash sweetener 2010-12-15T14:11:58Z Cough is less common with drugs such as Cozaar and Diovan. People's Pharmacy: How to avoid bedbugs when you travel 2010-09-01T20:45:00Z Doctors wrote fewer Diovan prescriptions in the first quarter as generic competitors went on sale in Spain, Canada and Brazil. Novartis Gains as First-Quarter Profit, Sales Beat Estimates 2011-04-19T08:33:31Z Novartis is seeking to diversify and insulate itself against losing patent protection on big selling medicines, such as blood pressure drug Diovan, by buying Alcon. Novartis to push ahead with disputed Alcon buyout 2010-08-26T10:29:00Z |
| 随便看 |
英语例句辞典收录了117811条英语例句在线翻译词条，基本涵盖了全部常用单词及词组的例句翻译及用法，是英语学习的有利工具。